Apellis Pharmaceuticals Inc (APLS)
28.06
-0.19
(-0.67%)
USD |
NASDAQ |
Nov 14, 16:00
28.06
0.00 (0.00%)
After-Hours: 06:51
Apellis Pharmaceuticals Cash and Short Term Investments (Quarterly): 396.86M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 396.86M |
| June 30, 2024 | 360.09M |
| March 31, 2024 | 325.92M |
| December 31, 2023 | 351.18M |
| September 30, 2023 | 452.41M |
| June 30, 2023 | 616.26M |
| March 31, 2023 | 765.08M |
| December 31, 2022 | 551.80M |
| September 30, 2022 | 708.55M |
| June 30, 2022 | 852.80M |
| March 31, 2022 | 965.30M |
| December 31, 2021 | 700.55M |
| September 30, 2021 | 430.31M |
| June 30, 2021 | 599.01M |
| March 31, 2021 | 723.67M |
| December 31, 2020 | 877.65M |
| September 30, 2020 | 728.16M |
| June 30, 2020 | 832.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 646.69M |
| December 31, 2019 | 351.98M |
| September 30, 2019 | 433.99M |
| June 30, 2019 | 289.13M |
| March 31, 2019 | 288.25M |
| December 31, 2018 | 176.27M |
| September 30, 2018 | 220.64M |
| June 30, 2018 | 253.84M |
| March 31, 2018 | 152.93M |
| December 31, 2017 | 175.64M |
| September 30, 2017 | 13.14M |
| June 30, 2017 | 52.19M |
| December 31, 2016 | 24.86M |
| December 31, 2015 | 36.00M |
| September 30, 2015 | 10.03M |
| June 30, 2015 | 14.86M |
| December 31, 2014 | 13.62M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
325.92M
Minimum
Mar 2024
965.30M
Maximum
Mar 2022
611.86M
Average
631.48M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 930.44M |
| Ionis Pharmaceuticals Inc | 2.483B |
| EyePoint Pharmaceuticals Inc | 253.79M |
| Cassava Sciences Inc | 148.98M |
| Macrogenics Inc | 200.36M |